Montelukast Prescribing at MAPESBURY MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
382
Total Quantity
6,426
NHS Cost
£358
vs National Avg
-44.2%
MAPESBURY MEDICAL GROUP prescribed 382 items of Montelukast over the last 12 months at a cost of £358 to the NHS. This is 44.2% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
38
Jul 2026
37
Jul 2026
37
Jul 2026
26
Jul 2026
23
Jul 2026
38
Jul 2026
29
Jul 2026
42
Jul 2026
27
Jul 2026
27
Jul 2026
25
Jul 2026
33
Prescribing Details
| Total Items | 382 |
|---|---|
| Total Quantity | 6,426 |
| Total NHS Cost | £358 |
| Presentations | 4 different forms |
| vs National Average | -44.2% |
Montelukast Prescribing Comparison
| This practice | 382 items |
|---|---|
| National average per practice | 685 items |
| Difference | -44.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.